Use of botulinum toxin in Frey's syndrome
- PMID: 30899477
- PMCID: PMC6406149
- DOI: 10.1002/ccr3.2019
Use of botulinum toxin in Frey's syndrome
Abstract
Frey's syndrome is the most common adverse event after parotidectomy, and usually, it appears after 6 months. In our case, symptoms appear 20 years from surgery, an uncommon condition. Intralesional botulinum toxin gives excellent results in therapy, regardless of the time elapsed between surgery and the first treatment.
Keywords: Frey syndrome; Mikulicz syndrome; Minor test; Sjogren syndrome; botulinum toxin; parotidectomy.
Conflict of interest statement
None declared.
Figures
References
-
- Linder TE, Huber A, Schmid S. Frey’s syndrome after parotidectomy: a retrospective and prospective analysis. Laryngoscope. 1997;107:1496‐1501. - PubMed
-
- Ford FR, Woodhall R. Phenomena due to misdirection of regenerating fibres of cranial, spinal and automatic nerves, clinical observations. Arch Surg. 1938;36:480‐496.
-
- Tugnoli V, Marchese Ragona R, Eleopra R, et al. The role of gustatory flushing in Frey’s syndrome and its treatment with botulinum toxin type A. Clin Auton Res. 2002;12:174‐178. - PubMed
-
- Galletti B, Gazia F, Freni F, Sireci F, Galletti F. Endoscopic sinus surgery with and without computer assisted navigation: A retrospective study. Auris Nasus Larynx. 2018. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
